Advancing emergency department-initiated buprenorphine
- PMID: 34179878
- PMCID: PMC8208651
- DOI: 10.1002/emp2.12451
Advancing emergency department-initiated buprenorphine
Abstract
Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.
Keywords: ED‐initiated buprenorphine; medication for opioid use disorder; opioid use disorder; treatment engagement.
© 2021 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of American College of Emergency Physicians.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- American Medical Association Advocacy Resource Center . Issue brief: reports of increases in opioid related overdose and other concerns during covid pandemic. https://www.ama‐assn.org/system/files/2020‐07/issue‐brief‐increases‐in‐o.... Updated April 15, 2021. Accessed May 2021.
-
- Hedegaard H, Minino A, Warner M. Drug overdose deaths in the United States, 1999‐2019. NCHS Data Brief. 2020(394):1‐8. https://www.cdc.gov/nchs/products/databriefs/db394.htm. Published December 2020. Accessed February 2021.
-
- Ahmad F, LM R, Sutton P, Provisional drug overdose death counts. https://www.cdc.gov/nchs/nvss/vsrr/drug‐overdose‐data.htm Published 2021. Accessed January 2021.
LinkOut - more resources
Full Text Sources
